A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Exicure (XCUR) announced that the Australian Patent Office has issued Patent No. 2018388302, titled “GPCR Heteromer Inhibitors and Uses ...

Real-time stock price for NBI Diversified Emerging Markets Equ Fd Gpc$ 544 (NBC54489.CF), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Shares of Genuine Parts Co. GPC slipped 1.82% to $121.33 Wednesday, on what proved to be an all-around mixed trading session ...

The stock's fall snapped a four-day winning streak.